A detailed history of Stablepoint Partners, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Stablepoint Partners, LLC holds 33,094 shares of JNJ stock, worth $4.83 Million. This represents 0.98% of its overall portfolio holdings.

Number of Shares
33,094
Previous 33,075 0.06%
Holding current value
$4.83 Million
Previous $5.24 Billion 2.27%
% of portfolio
0.98%
Previous 1.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

BUY
$145.48 - $167.38 $2,764 - $3,180
19 Added 0.06%
33,094 $5.36 Billion
Q2 2024

Aug 02, 2024

BUY
$144.38 - $157.78 $326,587 - $356,898
2,262 Added 7.34%
33,075 $5.24 Billion
Q1 2024

Apr 23, 2024

BUY
$155.22 - $162.74 $790,069 - $828,346
5,090 Added 19.79%
30,813 $4.87 Billion
Q4 2023

Feb 12, 2024

BUY
$145.6 - $158.88 $3.75 Million - $4.09 Million
25,723 New
25,723 $4.03 Billion

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $381B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Stablepoint Partners, LLC Portfolio

Follow Stablepoint Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stablepoint Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stablepoint Partners, LLC with notifications on news.